ABSCI CORP Increase (Decrease) in Prepaid Expense and Other Assets
ABSCI CORP (ABSI) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-11
- ABSCI CORP increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $858.00K.
- ABSCI CORP increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $862.00K.
- ABSCI CORP increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $141.00K.
- ABSCI CORP increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $2.14M, a 7.74% increase year-over-year.
- ABSCI CORP increase (decrease) in prepaid expense and other assets for fiscal 2025 was $424.00K, a 12.40% decline from fiscal 2024.
- ABSCI CORP increase (decrease) in prepaid expense and other assets for fiscal 2024 was $484.00K.
- ABSCI CORP increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.60M.
- ABSCI CORP increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.38M, a 131.19% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $858.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.72M 10-Q · filed 2026-08-11 | $1.86M derived: sum of 3 quarters · filed 2026-08-11 | $4.00M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $862.00K 10-Q · filed 2026-05-07 | $1.00M derived: sum of 2 quarters · filed 2026-05-07 | $3.15M derived: sum of 3 quarters · filed 2026-05-07 | $2.21M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $2.28M derived: sum of 2 quarters · filed 2026-03-24 | $1.35M derived: sum of 3 quarters · filed 2026-08-11 | $424.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.21M derived: sum of 2 quarters · filed 2026-08-11 | $283.00K 10-Q · filed 2025-11-12 | -$225.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$936.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$1.86M 10-Q · filed 2026-08-11 | -$2.37M derived: sum of 3 quarters · filed 2026-08-11 | -$379.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$924.00K 10-Q · filed 2026-05-07 | -$1.43M derived: sum of 2 quarters · filed 2026-05-07 | $557.00K derived: sum of 3 quarters · filed 2026-05-07 | $80.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.48M derived: sum of 2 quarters · filed 2026-03-24 | $1.00M derived: sum of 3 quarters · filed 2026-03-24 | $484.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.51M derived: sum of 2 quarters · filed 2025-11-12 | $992.00K 10-Q · filed 2025-11-12 | $854.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$477.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$997.00K 10-Q · filed 2025-08-12 | -$1.14M derived: sum of 3 quarters · filed 2025-08-12 | -$1.96M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$520.00K 10-Q · filed 2025-05-13 | -$658.00K derived: sum of 2 quarters · filed 2025-05-13 | -$1.49M derived: sum of 3 quarters · filed 2025-05-13 | -$965.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$966.00K derived: sum of 2 quarters · filed 2025-03-18 | -$445.00K derived: sum of 3 quarters · filed 2025-03-18 | -$1.60M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$828.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$307.00K derived: sum of 2 quarters · filed 2024-11-12 | -$1.46M 10-Q · filed 2024-11-12 | -$406.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $521.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$632.00K 10-Q · filed 2024-08-14 | $422.00K derived: sum of 3 quarters · filed 2024-08-14 | -$1.31M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$1.15M 10-Q · filed 2024-05-14 | -$99.00K derived: sum of 2 quarters · filed 2024-05-14 | -$1.83M derived: sum of 3 quarters · filed 2024-05-14 | -$1.73M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$681.00K derived: sum of 2 quarters · filed 2024-03-21 | -$581.00K derived: sum of 3 quarters · filed 2024-03-21 | -$2.38M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.64M derived: sum of 2 quarters · filed 2023-11-14 | -$3.44M 10-Q · filed 2023-11-14 | -$4.27M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.70M 10-Q · filed 2023-08-14 | -$2.54M derived: sum of 3 quarters · filed 2023-08-14 | $5.01M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$1.80M 10-Q · filed 2023-05-15 | -$2.64M derived: sum of 2 quarters · filed 2023-05-15 | $4.91M derived: sum of 3 quarters · filed 2023-05-15 | $5.14M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$836.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $6.71M derived: sum of 2 quarters · filed 2023-03-30 | $6.95M derived: sum of 3 quarters · filed 2023-03-30 | $7.64M 10-K · filed 2023-03-30 |
| 2021-09-30 | $7.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $7.78M derived: sum of 2 quarters · filed 2022-11-09 | $8.47M 10-Q · filed 2022-11-09 | $9.94M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $921.00K 10-Q · filed 2022-08-11 | $2.39M derived: sum of 3 quarters · filed 2022-08-11 | $2.13M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $690.00K 10-Q · filed 2022-05-11 | $2.15M derived: sum of 2 quarters · filed 2022-05-11 | $1.90M derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.21M derived: sum of 2 quarters · filed 2022-03-22 | $1.43M 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$31.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $229.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |